JP4561559B2 - High-intensity sweetener-containing beverage - Google Patents
High-intensity sweetener-containing beverage Download PDFInfo
- Publication number
- JP4561559B2 JP4561559B2 JP2005277131A JP2005277131A JP4561559B2 JP 4561559 B2 JP4561559 B2 JP 4561559B2 JP 2005277131 A JP2005277131 A JP 2005277131A JP 2005277131 A JP2005277131 A JP 2005277131A JP 4561559 B2 JP4561559 B2 JP 4561559B2
- Authority
- JP
- Japan
- Prior art keywords
- beverage
- sweetness
- mass
- intensity sweetener
- sucrose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013361 beverage Nutrition 0.000 title claims description 30
- 239000008123 high-intensity sweetener Substances 0.000 title description 24
- 235000013615 non-nutritive sweetener Nutrition 0.000 title description 24
- 229930006000 Sucrose Natural products 0.000 claims description 15
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 15
- 239000005720 sucrose Substances 0.000 claims description 15
- 239000000796 flavoring agent Substances 0.000 claims description 13
- 235000019634 flavors Nutrition 0.000 claims description 12
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 11
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 11
- 229960004998 acesulfame potassium Drugs 0.000 claims description 11
- 239000000619 acesulfame-K Substances 0.000 claims description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000004376 Sucralose Substances 0.000 description 10
- 235000019408 sucralose Nutrition 0.000 description 10
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 10
- 239000003814 drug Substances 0.000 description 8
- 241000544066 Stevia Species 0.000 description 7
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 7
- 244000018633 Prunus armeniaca Species 0.000 description 6
- 235000009827 Prunus armeniaca Nutrition 0.000 description 6
- 239000008374 liqueur flavor Substances 0.000 description 6
- 235000013532 brandy Nutrition 0.000 description 5
- INAXVXBDKKUCGI-UHFFFAOYSA-N 4-hydroxy-2,5-dimethylfuran-3-one Chemical compound CC1OC(C)=C(O)C1=O INAXVXBDKKUCGI-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000167854 Bourreria succulenta Species 0.000 description 3
- 235000019693 cherries Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- IGJQUJNPMOYEJY-UHFFFAOYSA-N 2-acetylpyrrole Chemical compound CC(=O)C1=CC=CN1 IGJQUJNPMOYEJY-UHFFFAOYSA-N 0.000 description 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940064880 inositol 100 mg Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 229940089782 pyridoxine hydrochloride 5 mg Drugs 0.000 description 2
- 229950001574 riboflavin phosphate Drugs 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CFAKWWQIUFSQFU-UHFFFAOYSA-N 2-hydroxy-3-methylcyclopent-2-en-1-one Chemical compound CC1=C(O)C(=O)CC1 CFAKWWQIUFSQFU-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- IMKJGXCIJJXALX-SHUKQUCYSA-N Norambreinolide Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C)[C@@H]1[C@]2(C)OC(=O)C1 IMKJGXCIJJXALX-SHUKQUCYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 244000208734 Pisonia aculeata Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- IMKJGXCIJJXALX-UHFFFAOYSA-N ent-Norambreinolide Natural products C1CC2C(C)(C)CCCC2(C)C2C1(C)OC(=O)C2 IMKJGXCIJJXALX-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- -1 homofuronol Chemical compound 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 235000020098 plum wine Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 229940096995 sclareolide Drugs 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Non-Alcoholic Beverages (AREA)
Description
本発明は高甘味度甘味料を含有する飲料に関する。さらに詳しくは、ショ糖の代わりに高甘味度甘味料を配合した飲料において、ショ糖様の甘味質を付与する技術に関し、医薬品、医薬部外品及び食品の分野に応用できるものである。 The present invention relates to a beverage containing a high intensity sweetener. More specifically, the present invention relates to a technique for imparting a sucrose-like sweetness in a beverage containing a high-intensity sweetener instead of sucrose, and can be applied to the fields of pharmaceuticals, quasi drugs and foods.
一般に、医薬品、医薬部外品及び食品の分野における飲料には、良質な甘味を有するショ糖が含有されているが、近年、健康志向の向上に伴い、虫歯や肥満の原因となるショ糖を高甘味度甘味料で代替することが多くなってきている。このような高甘味度甘味料の代表的なものとして、スクラロース、ステビア及びアセスルファムカリウムを挙げることができる。これらの高甘味度甘味料はショ糖よりもはるかに強い甘味を有し、非常に少ない添加量でショ糖並の甘味を付与することが可能であるが、特有の苦味や甘味、雑味の後引きを有し、ボリューム感も不足することから、ショ糖と比較すると嗜好性の面で劣っている。 In general, beverages in the fields of pharmaceuticals, quasi-drugs and foods contain sucrose having a good sweetness. However, in recent years, with the improvement of health orientation, sucrose that causes tooth decay and obesity has been added. High-intensity sweeteners are increasingly being replaced. Typical examples of such high-intensity sweeteners include sucralose, stevia and acesulfame potassium. These high-intensity sweeteners have a much stronger sweetness than sucrose and can give sweetness similar to sucrose with a very small addition amount. Since it has a pull-back and lacks volume, it is inferior in terms of palatability compared to sucrose.
そこで、特開2003−235496号では、フラネオール、ホモフロノール、マルトール、コリロン、2−アセチルピロール及びスクラレオライドなどをスクラロースやアセスルファムカリウムといった高甘味度甘味料と併用して甘味質を改善する方法が開示されている(特許文献1参照)。 Japanese Patent Application Laid-Open No. 2003-235396 discloses a method for improving sweetness by combining furaneol, homofuronol, maltol, corylone, 2-acetylpyrrole, sclareolide, etc. with a high-intensity sweetener such as sucralose or acesulfame potassium. (See Patent Document 1).
しかしながら、この方法ではフラネオール等の化合物自体に特異的な味があり、スクラロース等の高甘味度甘味料の甘味質改善に必要な量を添加すると添加物自体の特異的な味が顕現し、飲料全体の風味が悪化するという問題があった。 However, in this method, the compound itself such as furaneol has a specific taste, and when the amount necessary for improving the sweetness of a high-intensity sweetener such as sucralose is added, the specific taste of the additive itself is manifested. There was a problem that the overall flavor deteriorated.
本発明は、ショ糖の一部または全てを高甘味度甘味料で代替し、高甘味度甘味料の甘味質をショ糖様に改善し、服用性に優れた高甘味度甘味料含有低カロリー飲料を提供することを課題とする。 The present invention replaces part or all of sucrose with a high-intensity sweetener, improves the sweetness of the high-intensity sweetener in a sucrose-like manner, and contains a high-intensity sweetener containing low calories. An object is to provide a beverage.
本発明者らは、前記課題を解決するために鋭意研究を重ねた結果、スクラロース等の高甘味度甘味料を配合した飲料において、梅酒様、杏仁酒様、アマレット様、アプリコットブランデー様、チェリーブランデー様等のリキュール系フレーバーを配合することにより高甘味度甘味料の甘味質がショ糖様に改善されることを見出し、本発明を完成するに到った。 As a result of intensive studies to solve the above-mentioned problems, the present inventors have found that in beverages containing a high-sweetness sweetener such as sucralose, plum wine-like, apricot sake-like, amaretto-like, apricot brandy-like, cherry brandy The present inventors have found that the sweetness of a high-intensity sweetener can be improved like a sucrose by adding a liqueur-type flavor such as the above.
すなわち本発明は、高甘味度甘味料、及び該高甘味度甘味料の1質量部に対して0.1質量部以上のリキュール系フレーバーを含有することを特徴とする飲料である。 That is, the present invention is a beverage characterized by containing a high-intensity sweetener and 0.1 parts by mass or more of liqueur flavor with respect to 1 part by mass of the high-intensity sweetener.
本発明により、ショ糖の一部または全てを高甘味度甘味料で代替したにも関わらず、ショ糖様の甘味質を有する飲料を提供することが可能となった。 According to the present invention, it is possible to provide a beverage having a sucrose-like sweetness quality, even though part or all of sucrose is replaced with a high-intensity sweetener.
「高甘味度甘味料」としては、例えば、スクラロース、ステビア、アセスルファムカリウム、サッカリンナトリウム、アスパルテーム、グリチルリチン、グリリルリチン酸ジカリウム及びソーマチンが挙げられる。好ましいのは、スクラロース、ステビア及びアセスルファムカリウムである。これら高甘味度甘味料は、1種を用いるだけでなく、2種以上を組み合わせて用いてもよい。 Examples of the “high-intensity sweetener” include sucralose, stevia, acesulfame potassium, saccharin sodium, aspartame, glycyrrhizin, dipotassium glycyrrhizinate and thaumatin. Preference is given to sucralose, stevia and acesulfame potassium. These high-intensity sweeteners may be used alone or in combination of two or more.
高甘味度甘味料の配合(含有)量は、高甘味度甘味料の種類にもよるが、通常、飲料100mL当たり0.2g以下、好ましくは0.1〜0.001gである。100mL当たり0.2gを超えると甘味が強すぎ、その甘味質を改善するためのフレーバー添加量が過大となって好ましくないからである。具体的には、スクラロースで100mL当たり0.001〜0.03gが好ましく、ステビアで100mL当たり0.001〜0.1gが好ましく、アセスルファムカリウムで100mL当たり0.001〜0.1gが好ましい。 Although the amount (content) of the high-intensity sweetener depends on the type of high-intensity sweetener, it is usually 0.2 g or less, preferably 0.1 to 0.001 g per 100 mL of beverage. This is because if the amount exceeds 0.2 g per 100 mL, the sweetness is too strong, and the amount of flavor added to improve the sweetness is excessive, which is not preferable. Specifically, 0.001-0.03 g per 100 mL is preferable for sucralose, 0.001-0.1 g per 100 mL is preferable for stevia, and 0.001-0.1 g per 100 mL is preferable for acesulfame potassium.
「リキュール系フレーバー」は、ベンズアルデヒドを含むフレーバーであり、中でも、梅酒様、杏仁酒様、アマレット様、アプリコットブランデー様、チェリーブランデー様のものが好ましく、アマレット様及びチェリーブランデー様のものが特に好ましい。本発明で用いるリキュール系フレーバーは、0.5〜50質量%のオイルベースと50〜99.5質量%の溶剤成分からなる。 “Liqueur flavors” are benzaldehyde-containing flavors, among which Umeshu, Apricot, Amaretto, Apricot Brandy, Cherry Brandy, and Amaretto and Cherry Brandy are particularly preferred. The liqueur flavor used in the present invention comprises 0.5 to 50% by mass of an oil base and 50 to 99.5% by mass of a solvent component.
リキュール系フレーバーの配合(含有)量は、香料のオイルベース量により異なるが、高甘味度甘味料の1重量部に対して、通常0.1質量部以上であり、0.1〜100質量部である。リキュール系フレーバーの配合量が0.1質量部未満であると高甘味度甘味料の甘味質改善作用が充分でなく、100質量部を超えると飲料全体の風味を却って損なうため、好ましくないからである。具体的には、スクラロースの1質量部に対して、0.1質量部以上、0.1〜100質量部が好ましく、0.1〜25質量部がさらに好ましい。ステビアの1質量部に対して、0.1質量部以上、0.1〜100質量部が好ましく、0.1〜25質量部がさらに好ましい。アセスルファムカリウムの1質量部に対して、0.1質量部以上、0.1〜100質量部が好ましく、0.1〜25質量部がさらに好ましい。 The blending (content) amount of the liqueur flavor varies depending on the oil base amount of the fragrance, but is usually 0.1 parts by mass or more and 0.1 to 100 parts by mass with respect to 1 part by weight of the high-intensity sweetener. It is. If the blending amount of the liqueur flavor is less than 0.1 parts by mass, the sweetness improving effect of the high-intensity sweetener is not sufficient, and if it exceeds 100 parts by mass, the flavor of the entire beverage is impaired, which is not preferable. is there. Specifically, 0.1 part by mass or more and 0.1 to 100 parts by mass are preferable, and 0.1 to 25 parts by mass is more preferable with respect to 1 part by mass of sucralose. 0.1 mass part or more and 0.1-100 mass parts are preferable with respect to 1 mass part of stevia, and 0.1-25 mass parts is more preferable. 0.1 mass part or more and 0.1-100 mass parts are preferable with respect to 1 mass part of acesulfame potassium, and 0.1-25 mass parts is more preferable.
梅酒様、杏仁酒様、アマレット様、アプリコットブランデー様、チェリーブランデー様の各リキュール系フレーバーは、1種を用いるだけでなく、2種以上を組み合わせて用いてもよい。 Each liqueur flavor such as plum wine, apricot sake, amaretto, apricot brandy, and cherry brandy may be used alone or in combination of two or more.
本発明の「飲料」は、飲料全体の風味及び甘味質改善作用の点から、そのpHは酸性域にあることが好ましく、pH2〜6がより好ましく、pH2.5〜5がさらに好ましい。pHが2未満になると前記高甘味度甘味料の安定性が悪くなり、pHが6を超えると飲料全体の風味が悪化して好ましくないからである。 The “beverage” of the present invention is preferably in the acidic range, more preferably in the range of pH 2 to 6, and more preferably in the range of pH 2.5 to 5, from the viewpoint of the flavor and sweetness improving action of the whole beverage. This is because when the pH is less than 2, the stability of the high-intensity sweetener is deteriorated, and when the pH is more than 6, the flavor of the whole beverage is deteriorated, which is not preferable.
ここで、飲料のpH調整には、可食性の酸を用いることができ、具体的には、クエン酸、リンゴ酸、酒石酸、フマル酸、乳酸、コハク酸、アスコルビン酸などの有機酸及びそれらの塩類、塩酸、リン酸などの無機酸及びそれらの塩類などが挙げられる。これらのpH調整剤は1種を用いるだけでなく、2種以上を組み合わせて用いてもよい。 Here, an edible acid can be used to adjust the pH of the beverage. Specifically, citric acid, malic acid, tartaric acid, fumaric acid, lactic acid, succinic acid, ascorbic acid and other organic acids and their Examples thereof include salts, inorganic acids such as hydrochloric acid and phosphoric acid, and salts thereof. These pH adjusters may be used alone or in combination of two or more.
なお、ショ糖を減量し、その分の甘味を高甘味度甘味料で代替しつつ、ショ糖様の甘味質を維持し、低カロリーの飲料を提供するという本発明の趣旨からいって、ショ糖の配合(含有)量はできるだけ少ないことが好ましく、具体的には、100mL当たり5g以下であることが好ましい。しかしながら、ショ糖の配合量を減量し、甘味の低下を高甘味度甘味料で代替すればその分の低カロリー化は図れるので、本発明の「飲料」にはショ糖を配合してもよく、その配合(含有)量にも特に制限はない。 It should be noted that the amount of sucrose is reduced, and the sweetness of the sucrose is replaced with a high-intensity sweetener while maintaining the sucrose-like sweetness and providing a low-calorie beverage. The amount (contained) of sugar is preferably as small as possible, and specifically, it is preferably 5 g or less per 100 mL. However, if the amount of sucrose is reduced and the sweetness reduction is replaced with a high-intensity sweetener, the amount of calories can be reduced, so sucrose may be added to the “beverage” of the present invention. The blending (content) content is not particularly limited.
また、本発明の飲料は、低カロリー飲料であることが好ましく、具体的には100mL当たり20kcal以下であることが好ましい。 Moreover, it is preferable that the drink of this invention is a low calorie drink, and it is preferable that it is specifically 20 kcal or less per 100 mL.
さらに、本発明の効果を損なわない範囲で、各種ビタミン及びその塩類、ミネラル、アミノ酸及びその塩類、生薬及び生薬抽出物、前記以外の甘味剤、保存剤、矯味剤、着色剤など飲料一般に使用される成分を配合することができる。 Furthermore, various vitamins and salts thereof, minerals, amino acids and salts thereof, herbal medicines and herbal extracts, sweeteners other than those described above, preservatives, flavoring agents, coloring agents and the like are generally used within the range not impairing the effects of the present invention. Ingredients can be blended.
本発明の飲料は、常法により調製でき、例えば、各成分を規定量以下の精製水にて混合し、規定量に容量調整し、必要に応じて濾過、滅菌処理を施すことにより調製される。なお、脂溶性ビタミンを含むときは、通常用いられる界面活性剤または可溶化剤により乳化または可溶化してもよく、分散剤を用いて懸濁させてもよい。 The beverage of the present invention can be prepared by a conventional method. For example, the beverage is prepared by mixing each component with a specified amount or less of purified water, adjusting the volume to a specified amount, and performing filtration and sterilization as necessary. . When fat-soluble vitamins are included, they may be emulsified or solubilized with commonly used surfactants or solubilizers, or suspended using a dispersant.
本発明の飲料は、清涼飲料、健康飲料、栄養補給飲料など食品分野の各種飲料、ドリンク剤やシロップ剤などの医薬品、医薬部外品として提供できる。 The beverage of the present invention can be provided as various beverages in the food field such as soft drinks, health drinks and nutritional supplement beverages, pharmaceuticals such as drinks and syrups, and quasi drugs.
以下に、実施例、比較例及び試験例を挙げ、本発明をさらに詳細に説明する。 Hereinafter, the present invention will be described in more detail with reference to Examples, Comparative Examples and Test Examples.
(試験例1)
表1記載の成分を精製水に混合溶解し、クエン酸でpHを3.0に調整後、80℃で30分間滅菌し、実験例1〜9及び比較例1〜7の飲料を得た。
各飲料につき、7人のパネルにより甘味質を評価した。結果を表1に示す。
なお、評価基準は次のとおりである。
(Test Example 1)
The ingredients listed in Table 1 were mixed and dissolved in purified water, adjusted to pH 3.0 with citric acid, and sterilized at 80 ° C. for 30 minutes to obtain beverages of Experimental Examples 1-9 and Comparative Examples 1-7.
For each beverage, the sweetness was assessed by a panel of 7 people. The results are shown in Table 1.
The evaluation criteria are as follows.
甘味質の評価
◎:非常に甘味質がよい
○:甘味質がよい
△:甘味質がややよい
×:甘味質が悪い
Evaluation of sweetness ◎: Very good sweetness ○: Good sweetness △: Slightly good sweetness ×: Poor sweetness
(実施例10)
硝酸チアミン 5mg
リン酸リボフラビンナトリウム 5mg
塩酸ピリドキシン 5mg
アスコルビン酸ナトリウム 5mg
ニコチン酸アミド 25mg
無水カフェイン 50mg
イノシトール 100mg
アミノエチルスルホン酸 1000mg
ソルビトール 1000mg
エリスリトール 1000mg
キシリトール 1000mg
ショ糖 1000mg
スクラロース 5mg
ステビア 2mg
安息香酸ナトリウム 50mg
氷酢酸 0.5mg
アマレット様フレーバー 10mg
梅酒様フレーバー 50mg
クエン酸 適量(pH3.5)
上記成分を精製水に混合溶解し、全量100mLの飲料を得た。
(Example 10)
Thiamine nitrate 5mg
Riboflavin sodium phosphate 5mg
Pyridoxine hydrochloride 5mg
Sodium ascorbate 5mg
Nicotinamide 25mg
Anhydrous caffeine 50mg
Inositol 100mg
Aminoethylsulfonic acid 1000mg
Sorbitol 1000mg
Erythritol 1000mg
Xylitol 1000mg
Sucrose 1000mg
Sucralose 5mg
Stevia 2mg
Sodium benzoate 50mg
Glacial acetic acid 0.5mg
Amaretto flavor 10mg
Plum wine-like flavor 50mg
Citric acid appropriate amount (pH 3.5)
The above components were mixed and dissolved in purified water to obtain a total amount of 100 mL of beverage.
(実施例11)
硝酸チアミン 5mg
リン酸リボフラビンナトリウム 5mg
塩酸ピリドキシン 5mg
ニコチン酸アミド 25mg
無水カフェイン 50mg
イノシトール 100mg
アミノエチルスルホン酸 1000mg
ソルビトール 3000mg
アセスルファムカリウム 30mg
スクラロース 5mg
ステビア 5mg
安息香酸ナトリウム 50mg
氷酢酸 1mg
チェリーブランデー様フレーバー 100mg
クエン酸 適量(pH3.0)
上記成分を精製水に混合溶解し、全量100mLの飲料を得た。
(Example 11)
Thiamine nitrate 5mg
Riboflavin sodium phosphate 5mg
Pyridoxine hydrochloride 5mg
Nicotinamide 25mg
Anhydrous caffeine 50mg
Inositol 100mg
Aminoethylsulfonic acid 1000mg
Sorbitol 3000mg
Acesulfame potassium 30mg
Sucralose 5mg
Stevia 5mg
Sodium benzoate 50mg
Glacial acetic acid 1mg
Cherry brandy flavor 100mg
Citric acid appropriate amount (pH3.0)
The above components were mixed and dissolved in purified water to obtain a total amount of 100 mL of beverage.
本発明により、ショ糖様の上質の甘味質を有し、低カロリーの飲料を医薬品、医薬部外品及び食品の各分野において提供することが期待される。
According to the present invention, it is expected to provide a sucrose-like high-quality sweetness and a low-calorie beverage in the fields of pharmaceuticals, quasi drugs and foods.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005277131A JP4561559B2 (en) | 2005-09-26 | 2005-09-26 | High-intensity sweetener-containing beverage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005277131A JP4561559B2 (en) | 2005-09-26 | 2005-09-26 | High-intensity sweetener-containing beverage |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007082491A JP2007082491A (en) | 2007-04-05 |
JP4561559B2 true JP4561559B2 (en) | 2010-10-13 |
Family
ID=37970106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005277131A Active JP4561559B2 (en) | 2005-09-26 | 2005-09-26 | High-intensity sweetener-containing beverage |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4561559B2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
JP5927038B2 (en) * | 2012-05-25 | 2016-05-25 | ライオン株式会社 | Bone formation promoter |
WO2013176054A1 (en) * | 2012-05-25 | 2013-11-28 | ライオン株式会社 | Agent containing ascorbic acid derivative, and use for said agent |
CN112771145A (en) * | 2018-06-15 | 2021-05-07 | 三宝乐啤酒株式会社 | High-alcohol beverage, method for producing same, and method for improving flavor of high-alcohol beverage |
US20240115576A1 (en) * | 2020-10-29 | 2024-04-11 | Oye Therapeutics, Inc | Caffeine Compositions |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000262259A (en) * | 1999-03-19 | 2000-09-26 | Taisho Pharmaceut Co Ltd | Drink |
JP2001010955A (en) * | 1999-06-24 | 2001-01-16 | Taisho Pharmaceut Co Ltd | Internal administration solution composition |
WO2002067702A1 (en) * | 2001-02-27 | 2002-09-06 | San-Ei Gen F.F.I., Inc. | Carbonated drinks |
WO2003007734A1 (en) * | 2001-07-19 | 2003-01-30 | San-Ei Gen F.F.I., Inc. | Flavor-improving compositions and application thereof |
JP2004305088A (en) * | 2003-04-07 | 2004-11-04 | Taisho Pharmaceut Co Ltd | Drink composition |
-
2005
- 2005-09-26 JP JP2005277131A patent/JP4561559B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000262259A (en) * | 1999-03-19 | 2000-09-26 | Taisho Pharmaceut Co Ltd | Drink |
JP2001010955A (en) * | 1999-06-24 | 2001-01-16 | Taisho Pharmaceut Co Ltd | Internal administration solution composition |
WO2002067702A1 (en) * | 2001-02-27 | 2002-09-06 | San-Ei Gen F.F.I., Inc. | Carbonated drinks |
WO2003007734A1 (en) * | 2001-07-19 | 2003-01-30 | San-Ei Gen F.F.I., Inc. | Flavor-improving compositions and application thereof |
JP2004305088A (en) * | 2003-04-07 | 2004-11-04 | Taisho Pharmaceut Co Ltd | Drink composition |
Also Published As
Publication number | Publication date |
---|---|
JP2007082491A (en) | 2007-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5081255B2 (en) | LHG composition for reducing the persistent bitter taste of steviol glycosides | |
EP2793621B1 (en) | Sweetened beverages | |
US6265012B1 (en) | Reduction of lingering sweet aftertaste of sucralose | |
JP4964969B2 (en) | Dietary beverage products containing rebaudioside A, erythritol or tagatose and acidulants | |
CA2656190C (en) | Ammoniated glycyrrhizin modified sweetened beverage products | |
JP4561559B2 (en) | High-intensity sweetener-containing beverage | |
CN101662957A (en) | Anisic acid modified steviol glycoside sweetened beverage products | |
JP2010521167A (en) | Natural beverage products | |
WO2014017485A1 (en) | Food or beverage containing fruit juice | |
US12016358B2 (en) | Composition comprising taste modulation compounds, their use and foodstuff comprising them | |
JP4816236B2 (en) | Sweetener-containing beverage | |
US20070178193A1 (en) | Mineral-fortified beverage composition | |
US20090074927A1 (en) | Cinnamic Acid To Inhibit Heat- And Light-Induced Benzene Formation In Benzoate-Preserved Carbonated And Non-Carbonated Beverages And Foods While Maintaining Or Improving Product Microbial Stability | |
EP0792589B2 (en) | Use of erythritol in soft drinks | |
JP4548836B2 (en) | High-intensity sweetener-containing beverage | |
US20210015133A1 (en) | Composition comprising taste modulation compounds, their use and foodstuff comprising them | |
CA2322825C (en) | Beverage comprising an effective amount of flavanols as sweetness cutting composition | |
EP4171259B1 (en) | Taste-neutral bitter blocker and uses thereof | |
JP2010183911A (en) | Beverage containing high-intensity sweetener | |
JP2021165256A (en) | Beverage composition | |
JP6528362B2 (en) | Beverage | |
JP4362025B2 (en) | Enhancement of beverage flavor | |
JP2006169178A (en) | Copper-containing composition for oral administration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080827 |
|
RD07 | Notification of extinguishment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7427 Effective date: 20090624 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100218 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100330 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100528 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100528 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100706 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100719 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130806 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4561559 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130806 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |